Brawn Biotech has communicated with shareholders who have not registered their email addresses.

The company has sent letters providing a weblink to access the Notice for the 41st Annual General Meeting and the Annual Report for the financial year 2025-26. This action ensures all shareholders can easily access important documents regarding the company's upcoming AGM and financial performance, promoting transparency and shareholder participation.